Immunai Stock

immunai.comBioTechFounded: 2018Funding to Date: $295.22MM

Immuani develops solutions for oncology treatments and auto-immune disorders by utilizing AI and ML technology to assist in mapping and to provide insights into the reprogramming of the immune system.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Immunai, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Immunai.

Register Today
Register for Details

For more details on financing and valuation for Immunai, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Immunai investors also invested in these private companies

Other companies like Immunai in the BioTech sector

Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$185MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$1.3B
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.89B